Clinical Trial Update: Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on combining vildagliptin with metformin for Type 2 Diabetes Mellitus patients starting basal insulin; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)
• metformin (metformin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 3 | Status: COMPLETED | Results posted: 2016-03-23